Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.75B |
| 2 |
Walmart Inc
WMT
|
+$3.98B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.42B |
| 4 |
Broadcom
AVGO
|
+$943M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$785M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$572M |
| 2 |
NVIDIA
NVDA
|
+$566M |
| 3 |
Apple
AAPL
|
+$554M |
| 4 |
AbbVie
ABBV
|
+$455M |
| 5 |
Bank of America
BAC
|
+$411M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.24% |
| 2 | Technology | 9.52% |
| 3 | Healthcare | 7.46% |
| 4 | Financials | 6.74% |
| 5 | Industrials | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
N-able
NABL
$792M
| $1.81M | ﹤0.01% |
241,394
-545,487
| -69% | -$4.16M |
|
3927
Lyell Immunopharma
LYEL
$356M
| $1.81M | ﹤0.01% |
58,651
-66,710
| -53% | -$1.49M |
|
3928
CorMedix
CRMD
$647M
| $1.8M | ﹤0.01% |
155,050
-240,404
| -61% | -$2.66M |
|
|
BIXIU
3929
Bitcoin Infrastructure Acquisition Corp Unit
BIXIU
| $1.8M | ﹤0.01% |
+181,000
| New | +$1.81M |
|
3930
CALL
Edison International
EIX
$27B
| $1.8M | ﹤0.01% |
30,000
+7,900
| +36% | +$453K |
|
3931
AAR Corp
AIR
$5.36B
| $1.8M | ﹤0.01% |
21,730
-8,848
| -29% | -$732K |
|
3932
CALL
Ferrari
RACE
$73.9B
| $1.79M | ﹤0.01% |
5,100
-7,300
| -59% | -$2.92M |
|
3933
Insperity
NSP
$2.04B
| $1.79M | ﹤0.01% |
46,293
-493,467
| -91% | -$19.7M |
|
3934
Richtech Robotics
RR
$412M
| $1.79M | ﹤0.01% |
+554,441
| New | +$2.45M |
|
3935
Northeast Community Bancorp
NECB
$364M
| $1.79M | ﹤0.01% |
79,010
-73,497
| -48% | -$1.55M |
|
3936
CALL
Teva Pharmaceuticals
TEVA
$42.5B
| $1.79M | ﹤0.01% |
57,200
-360,800
| -86% | -$8.89M |
|
|
ZBIO
3937
Zenas BioPharma
ZBIO
$2.04B
| $1.78M | ﹤0.01% |
49,160
-22,690
| -32% | -$746K |
|
3938
PUT
Fortis
FTS
$27.9B
| $1.78M | ﹤0.01% |
25,000
| – | – |
|
|
ORKA
3939
Oruka Therapeutics
ORKA
$6.03B
| $1.78M | ﹤0.01% |
+58,723
| New | +$1.64M |
|
3940
White Mountains Insurance
WTM
$5.1B
| $1.78M | ﹤0.01% |
856
-78
| -8% | -$153K |
|
|
ONT
3941
Onterris Inc
ONT
$598M
| $1.78M | ﹤0.01% |
71,586
-172,277
| -71% | -$4.55M |
|
3942
CALL
Bio-Techne
TECH
$11.3B
| $1.78M | ﹤0.01% |
30,200
-28,600
| -49% | -$1.74M |
|
3943
Mitsubishi UFJ Financial
MUFG
$258B
| $1.78M | ﹤0.01% |
111,923
-34,475
| -24% | -$533K |
|
|
AMTM
3944
Amentum Holdings
AMTM
$4.97B
| $1.77M | ﹤0.01% |
61,187
-579,612
| -90% | -$14.8M |
|
|
AMBQ
3945
Ambiq Micro
AMBQ
$1.39B
| $1.77M | ﹤0.01% |
+62,018
| New | +$1.78M |
|
3946
Shift4
FOUR
$3.47B
| $1.77M | ﹤0.01% |
28,065
-357,548
| -93% | -$25.3M |
|
3947
Digimarc Corp
DMRC
$135M
| $1.76M | ﹤0.01% |
268,986
+148,435
| +123% | +$1.26M |
|
|
EVOXU
3948
Evolution Global Acquisition Corp Units
EVOXU
| $1.76M | ﹤0.01% |
+175,000
| New | +$1.77M |
|
3949
PUT
Liquidia Corp
LQDA
$6.06B
| $1.76M | ﹤0.01% |
50,900
-36,600
| -42% | -$1.04M |
|
3950
GrowGeneration
GRWG
$95.5M
| $1.75M | ﹤0.01% |
1,169,137
-64,085
| -5% | -$105K |
|
Similar funds
Israel Englander's Q4 2025 Portfolio in Review
As of Q4 2025, Israel Englander held 6,645 positions worth $238B, up 1.5% from $234B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Israel Englander's Q4 2025 filing shows 668 new, 2,203 increased, 2,701 reduced and 696 closed positions. Its largest new stake was iShares Russell 1000 ETF: 455,129 shares worth $170M. The largest sale was Microsoft, an estimated $572M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q4 2025 buy was iShares Russell 1000 ETF: 455,129 shares worth $170M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $4.75B increase.
- Israel Englander's biggest Q4 2025 reduction was Microsoft, cutting an estimated $572M.
- Israel Englander fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Israel Englander's ten largest holdings make up 19% of its $238B portfolio in Q4 2025.
- Israel Englander opened 668 new positions and closed 696 in Q4 2025.
- Israel Englander's portfolio value rose 1.5% quarter-over-quarter to $238B.
Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.